v2vmedtech, inc.

Transcatheter edge-to-edge repair (TEER) has been established as the leading therapy for minimally invasive mitral valve insufficiency and is rapidly being adopted for the tricuspid valve.

v2vmedtech, inc. is an early-stage medical device company pioneering an innovative TEER system aimed at significant improvements in versatility over current TEER devices to expand the treatable patient population and improve outcomes in repair treatment both for the tricuspid and mitral valves.


Image of Wayne Paterson, board member

Wayne Paterson

Image of David St Denis, board member

David St Denis

Image of Vinnie Bapat, board member

Dr Vinnie Bapat


image of David St Denis, CEO

David St Denis


Image of Dr Vinnie Bapat, CMO

Dr Vinnie Bapat


Image of Matthew McDonnel, CFO

Matthew McDonnell


Medical Advisors

Image of Vinnie Bapat, medical advisor for v2vmedtech, inc

Dr Vinnie Bapat

Image of Mike McDonald, medical advisor for v2vmedtech, inc

Dr Mike McDonald

Image of Susheel Kodali, medical advisor for v2vmedtech, inc

Dr Susheel Kodali

Image of Chris Meduri, medical advisor for v2vmedtech, inc

Dr Chris Meduri


  • v2vmedtech, inc.
  • 860 Blue Gentian Road
  • Suite 340
  • Eagan, MN 55121
  • United States

If you have a query or interest in learning more about our company, please email us at